Highlights

  • Pfizer and German partner submit data for review for vaccine for kids 
  • CDC, FDA to review Pfizer's data and approval likely by Nov 1: sources to Bloomberg

Latest news

DC Fandome | 'The Flash' trailer teases fans with Michael Keaton's Batman

DC Fandome | 'The Flash' trailer teases fans with Michael Keaton's Batman

Your heart needs some extra TLC once you reach middle age. This study will set you in the right direction

Your heart needs some extra TLC once you reach middle age. This study will set you in the right direction

Kunal Khemmu wraps up shoot for 'Kanjoos Makkichoos' with Shweta Tripathi

Kunal Khemmu wraps up shoot for 'Kanjoos Makkichoos' with Shweta Tripathi

First film shot in the space: Russian filmmakers land after shoot aboard space station

First film shot in the space: Russian filmmakers land after shoot aboard space station

On camera: four hurt as speeding car rams into Durga procession in Bhopal

On camera: four hurt as speeding car rams into Durga procession in Bhopal

Pfizer covid vaccine likely for kids aged 5-11 in the United States from November first week

Pfizer finishes submitting data to the Food and Drug Administration ahead of an advisory panel meeting set for Oct. 26

Pfizer asked the U.S. government to allow use of its COVID-19 vaccine in children ages 5 to 11 in what would be a major expansion that could combat an alarming rise in serious infections in young children and help schools stay open. Bloomberg reports citing sources that a CDC meeting will be set for the week of Nov. 1, with clearance possibly coming as soon as the day of that meeting. 

A crucial topic of conversation at the FDA advisory meeting is likely to be the potential risk of myocarditis, or heart inflammation, in young kids who get the vaccine. Researchers are carefully monitoring rare cases of myocarditis that have occurred after messenger RNA shots, such as Pfizer’s. 

Also watch: UK scraps quarantine for fully vaccinated Indian travellers from October 11 

Pfizer and its German partner BioNTech said their research shows the younger kids should get one-third of the dose now given to everyone else. After their second dose, the 5- to 11-year-olds developed virus-fighting antibody levels just as strong as those that teens and young adults get from regular-strength shots.

Up Next

Pfizer covid vaccine likely for kids aged 5-11 in the United States from November first week

Pfizer covid vaccine likely for kids aged 5-11 in the United States from November first week

Firecracker stock story! This bet gave investors 1500% return

Firecracker stock story! This bet gave investors 1500% return

Mukesh Ambani's green shopping bag has two new investments ... again

Mukesh Ambani's green shopping bag has two new investments ... again

Reliance brands to acquire 40% stake in Manish Malhotra's designer label

Reliance brands to acquire 40% stake in Manish Malhotra's designer label

Mukesh Ambani now worth over 100 billion dollars! Just one rank below Warren Buffet in rich list

Mukesh Ambani now worth over 100 billion dollars! Just one rank below Warren Buffet in rich list

Sold out in seconds! Manish Malhotra becomes India's 1st designer to drop NFTs

Sold out in seconds! Manish Malhotra becomes India's 1st designer to drop NFTs